Why Did Otsuka Become A Leader In Virtual Trial Adoption?

In May 2020 Clinical Leader Live was proud to feature Brian Johnson, Director of Applied Innovation at Otsuka, and Katherine Vandebelt, Global Head of Clinical Innovation for Oracle to discuss whether pharma companies were ready to embrace virtual trials. During the presentation, Johnson and Vandebelt covered several topics, including how COVID-19 has changed the view of virtual trials, whether they will become a future best practice, how Otsuka opted to be a leader in the adoption of virtual technologies, the challenges and benefits of implementing virtual trials, incorporating virtual components into trial protocols, the impact these technologies can have on recruitment and retention, and therapeutic areas where virtual trials might have the biggest impact.

In this video, Johnson discusses why Otsuka chose to become an early adopter of virtual trial technologies.

Or click here to see the complete interview.